NEW YORK – Three years after consumer genomics firm Genos was acquired by NantOmics, the company is discontinuing its services.
"It is with great sadness [that] we would like to inform you that we have discontinued offering the Genos product and will stop supporting it beginning June 22. After that, your Genos portal will not be accessible," the company said in a message emailed to Genos customers on Monday, citing the ongoing pandemic as the reason for its decision.